These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 740691)

  • 1. Aluminium: removal from water supplies.
    Parkinson IS; Beckett A; Ward MK; Feest TG; Hoenich N; Strong A; Kerr DN
    Proc Eur Dial Transplant Assoc; 1978; 15():586-7. PubMed ID: 740691
    [No Abstract]   [Full Text] [Related]  

  • 2. Aluminium studies in dialysis encephalopathy.
    Elliott HL; Macdougall AI
    Proc Eur Dial Transplant Assoc; 1978; 15():157-63. PubMed ID: 740662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysis encephalopathy.
    Alfrey AC
    Kidney Int Suppl; 1986 Feb; 18():S53-7. PubMed ID: 3457997
    [No Abstract]   [Full Text] [Related]  

  • 4. [Two forerunners of the encephalopathy of hemodialysed patients : osteomalacic osteodystrophy and electroencephalographic alterations. Influence of the aluminium concentration in the dialysis fluid (author's transl)].
    Vecchierini-Blineau MF; Thébaud HE; Brochard D; Coville P
    Nephrologie; 1980; 1(1):29-32. PubMed ID: 7301017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialysate aluminium concentration and renal bone disease.
    Walker GS; Aaron JE; Peacock M; Robinson PJ; Davison AM
    Kidney Int; 1982 Feb; 21(2):411-5. PubMed ID: 7070002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low aluminium water, desferrioxamine, and dialysis encephalopathy.
    Milne FJ; Sharf B; Bell PD; Meyers AM
    Lancet; 1982 Aug; 2(8296):502. PubMed ID: 6125670
    [No Abstract]   [Full Text] [Related]  

  • 7. Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey.
    Parkinson IS; Ward MK; Feest TG; Fawcett RW; Kerr DN
    Lancet; 1979 Feb; 1(8113):406-9. PubMed ID: 84261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of aluminium dialysis encephalopathy after desferrioxamine treatment.
    Arze RS; Parkinson IS; Cartlidge NE; Britton P; Ward MK
    Lancet; 1981 Nov; 2(8255):1116. PubMed ID: 6118567
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dialysis and quality of the water].
    Brancaccio D; Piccoli G; Orlandini G; Sampaolo A
    Minerva Nefrol; 1982; 29(2):115. PubMed ID: 7133541
    [No Abstract]   [Full Text] [Related]  

  • 10. Critical concentrations of aluminium in water used for dialysis.
    Hodge KC; Day JP; O'Hara M; Ackrill P; Ralston AJ
    Lancet; 1981 Oct; 2(8250):802-3. PubMed ID: 6116918
    [No Abstract]   [Full Text] [Related]  

  • 11. Is aluminium a dementing ion?
    Lancet; 1992 Mar; 339(8795):713-4. PubMed ID: 1347589
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serum aluminum in hemodialysis patients. Relation to osteodystrophy, encephalopathy and aluminum hydroxide consumption].
    Nielsen LP; Heaf JG
    Ugeskr Laeger; 1983 May; 145(18):1363-7. PubMed ID: 6868163
    [No Abstract]   [Full Text] [Related]  

  • 13. Cela n'arrive qu'aux autres (aluminium intoxication only happens in the other nephrologist's dialysis centre).
    Simoes J; Barata JD; D'Haese PC; De Broe ME
    Nephrol Dial Transplant; 1994; 9(1):67-8. PubMed ID: 8177479
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidemic dialysis encephalopathy.
    Hocken AG
    Clin Nephrol; 1984 Feb; 21(2):140. PubMed ID: 6723114
    [No Abstract]   [Full Text] [Related]  

  • 15. Dialysis encephalopathy. Clinical, electroencephalographic and interventional aspects.
    O'Hare JA; Callaghan NM; Murnaghan DJ
    Medicine (Baltimore); 1983 May; 62(3):129-41. PubMed ID: 6341757
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of plasma aluminum in the detection and prevention of aluminum toxicity.
    Winney RJ; Cowie JF; Robson JS
    Kidney Int Suppl; 1986 Feb; 18():S91-5. PubMed ID: 3458005
    [No Abstract]   [Full Text] [Related]  

  • 17. Dialysis dementia: the role of dialysate pH in altering the dialyzability of aluminum.
    Gacek EM; Babb AL; Uvelli DA; Fry DL; Scribner BH
    Trans Am Soc Artif Intern Organs; 1979; 25():409-15. PubMed ID: 43004
    [No Abstract]   [Full Text] [Related]  

  • 18. Water supply aluminium concentration, dialysis dementia, and effect of reverse-osmosis water treatment.
    Davison AM; Walker GS; Oli H; Lewins AM
    Lancet; 1982 Oct; 2(8302):785-7. PubMed ID: 6126664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aluminum and renal bone disease in Australia.
    Dunstan CR; Evans RA
    Kidney Int Suppl; 1986 Feb; 18():S65-9. PubMed ID: 3457999
    [No Abstract]   [Full Text] [Related]  

  • 20. Progressive dialysis encephalopathy from dialysate aluminum.
    Rozas VV; Port FK; Rutt WM
    Arch Intern Med; 1978 Sep; 138(9):1375-7. PubMed ID: 686928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.